Founded in 2020, aCGT Vector is a member of the Irish Government-funded Healed Consortium. Holohan was a former medical adviser to the Department of Health. Irish cell therapy company aCGT Vector has ...
A scientific team is developing a new CAR T-cell gene therapy treatment for advanced metastatic prostate cancer at the Abramson Cancer Center of the University of Pennsylvania (Philadelphia, ...
NovaUCD-based Empiric Logic is helping aCGT Vector bring cellular therapy to patients faster using AI and data analytics. Dublin start-up Empiric Logic has partnered with Louth-based company aCGT ...
STAMFORD — The Alliance for Cancer Gene Therapy recently announced two grants totaling $500,000. But its leaders are already filling the funding pipeline to support future recipients. Describing ...
An innovative approach to tackling the challenges of pediatric sarcomas is being pursued by researchers at St. Jude Children's Research Hospital (Memphis, Tennessee) with a new grant from Alliance for ...
A scientific team led by Brian Brown, PhD, Professor of Genetics and Genomic Sciences and Associate Director of the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai (New ...
Recently, there was a gathering of scientists at the Hyatt Regency in Greenwich. They were there to discuss their latest findings in cancer research -- especially in the use of gene therapy in cancer ...
With a $500,000 Research Grant from Alliance for Cancer Gene Therapy (ACGT), Sidi Chen, PhD, assistant professor in the Department of Genetics and Systems Biology Institute at Yale School of Medicine ...
ACGT, Inc. has announced that its new accelerated DNA sequencing turnaround time exclusively to Chicago area researchers. With its “Rush” services, DNA samples prepared and ready for pickup in the ...
CHICAGO--(BUSINESS WIRE)--ACGT Sdn Bhd (“ACGT”) and Chromatin, Inc. jointly announce their intent to pursue a long term research agreement to develop mini-chromosome technology. Earlier today, Derrik ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results